MACRAE SANDY (PRESIDENT, CEO AND DIRECTOR) reported 1 transaction at SANGAMO THERAPEUTICS, INC
Review the transaction codes below to understand the nature of each event.
Filed: 1/24/2025ACC: 0001415889-25-002018
DirectorOfficer· PRESIDENT, CEO AND DIRECTOR
Since Feb 2026
-412.58K
Net shares
Net seller
$474.5K
Total sold
0
Open market trades
0B · 0S
1
Total transactions
412.58K disposed
Non-Derivative Transactions1
Common Stock
Direct
Shares
−412.58K
Price / share
$1.15
Trade value
$474.47K
% of position
16.4%
1/22/2025
2.51M→2.10M
Total
Net shares
−412.58K
Net value
-$474.47K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 1/22/2025 | F · Tax Withholding | −412.58K | $1.15 | $474.47K | 16.4% | 2.51M | 2.10M |
| Total | −412.58K | -$474.47K | ||||||
Derivative Transactions0
No derivative transactions reported